About this FactMed analysis covering adverse side effect reports of VORICONAZOLE patients who developed FORMICATION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking VORICONAZOLE reported FORMICATION to the FDA. A total of 4233 VORICONAZOLE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between VORICONAZOLE and FORMICATION. In doing so, we compare VORICONAZOLE with other drugs that cause FORMICATION, to help you evaluate whether or not VORICONAZOLE causes FORMICATION. Likewise, this page shows the most highly-reported side effects of VORICONAZOLE, so you can see if FORMICATION ranks among VORICONAZOLE's most well-known side effects.
Summary Statistics
Reports of VORICONAZOLE causing FORMICATION: 1
Reports of any side effect of VORICONAZOLE : 4233
Percentage of VORICONAZOLE patients where FORMICATION is a reported side effect: 0.0236%

FDA reports of any drug causing FORMICATION : 2415
Average percentage for all medicated patients where FORMICATION is reported as a complication: 0.0151%

Physician opinion on VORICONAZOLE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing VORICONAZOLE:
ASPERGILLOSIS ( 481 patients )
BRONCHOPULMONARY ASPERGILLOSIS ( 223 patients )
ANTIFUNGAL PROPHYLAXIS ( 185 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 151 patients )
FUNGAL INFECTION ( 130 patients )
PROPHYLAXIS ( 114 patients )
DRUG USE FOR UNKNOWN INDICATION ( 103 patients )
INFECTION PROPHYLAXIS ( 76 patients )
PNEUMONIA ( 30 patients )
CANDIDIASIS ( 23 patients )
ANTIFUNGAL TREATMENT ( 23 patients )
SYSTEMIC CANDIDA ( 19 patients )
INFECTION ( 16 patients )
PNEUMONIA FUNGAL ( 15 patients )
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC ( 14 patients )
ASPERGILLOMA ( 14 patients )
GASTROINTESTINAL CANDIDIASIS ( 11 patients )
PYREXIA ( 11 patients )
SEPSIS ( 10 patients )
KERATITIS FUNGAL ( 10 patients )
FEBRILE NEUTROPENIA ( 10 patients )
EYE INFECTION FUNGAL ( 9 patients )
TRICHOSPORON INFECTION ( 7 patients )
SCEDOSPORIUM INFECTION ( 7 patients )
SYSTEMIC MYCOSIS ( 7 patients )
OESOPHAGEAL CANDIDIASIS ( 6 patients )
EVIDENCE BASED TREATMENT ( 6 patients )
PNEUMONIA ASPIRATION ( 6 patients )
SYSTEMIC ANTIFUNGAL TREATMENT ( 6 patients )
FUSARIUM INFECTION ( 5 patients )
SINUSITIS ASPERGILLUS ( 5 patients )
ANTIBIOTIC PROPHYLAXIS ( 5 patients )
MUCORMYCOSIS ( 5 patients )
SEPTIC SHOCK ( 5 patients )
LUNG DISORDER ( 5 patients )
CHRONIC GRANULOMATOUS DISEASE ( 5 patients )
DERMATOPHYTOSIS ( 4 patients )
CEREBRAL ASPERGILLOSIS ( 4 patients )
MENINGITIS CRYPTOCOCCAL ( 4 patients )
ANTIVIRAL PROPHYLAXIS ( 4 patients )
RESPIRATORY MONILIASIS ( 4 patients )
RESPIRATORY TRACT INFECTION FUNGAL ( 4 patients )
ENDOCARDITIS ( 4 patients )
PSEUDOMONAS INFECTION ( 4 patients )
FUNGAEMIA ( 4 patients )
ILL-DEFINED DISORDER ( 4 patients )
LUNG ABSCESS ( 3 patients )
ENDOCARDITIS CANDIDA ( 3 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 3 patients )
SUPERINFECTION LUNG ( 3 patients )
PULMONARY NECROSIS ( 3 patients )
COCCIDIOIDOMYCOSIS ( 3 patients )
FUNGAL SEPSIS ( 3 patients )
LIVER ABSCESS ( 3 patients )
OROPHARYNGEAL CANDIDIASIS ( 3 patients )
OSTEOMYELITIS FUNGAL ( 3 patients )
PULMONARY MYCOSIS ( 3 patients )
RESPIRATORY TRACT INFECTION ( 3 patients )
ATYPICAL MYCOBACTERIAL INFECTION ( 2 patients )
MYCOSIS FUNGOIDES ( 2 patients )
OBLITERATIVE BRONCHIOLITIS ( 2 patients )
CANDIDA TEST POSITIVE ( 2 patients )
LUNG INFECTION ( 2 patients )
HEPATOSPLENIC CANDIDIASIS ( 2 patients )
PANCYTOPENIA ( 2 patients )
THERAPEUTIC PROCEDURE ( 2 patients )
CANDIDA SEPSIS ( 2 patients )
ANTI-INFECTIVE THERAPY ( 2 patients )
LUNG NEOPLASM ( 2 patients )
ZYGOMYCOSIS ( 2 patients )
STEM CELL TRANSPLANT ( 2 patients )
ANTIBIOTIC THERAPY ( 2 patients )
HYPERTHERMIA ( 2 patients )
PNEUMOCYSTIS JIROVECI PNEUMONIA ( 2 patients )
CRYPTOCOCCAL CUTANEOUS INFECTION ( 1 patients )
PNEUMONIA CRYPTOCOCCAL ( 1 patients )
TINEA INFECTION ( 1 patients )
FUNGAL SKIN INFECTION ( 1 patients )
RETINITIS ( 1 patients )
INTENTIONAL OVERDOSE ( 1 patients )
FUNGUS SEROLOGY TEST ( 1 patients )
POISONING ( 1 patients )
ULCERATIVE KERATITIS ( 1 patients )
CANDIDA PNEUMONIA ( 1 patients )
ACINETOBACTER INFECTION ( 1 patients )
ENCEPHALITIS ( 1 patients )
URINARY TRACT INFECTION ( 1 patients )
GEOTRICHUM INFECTION ( 1 patients )
OSTEOMYELITIS ( 1 patients )
SKIN INFECTION ( 1 patients )
ACUTE MYELOID LEUKAEMIA ( 1 patients )
WOUND INFECTION STAPHYLOCOCCAL ( 1 patients )
CELLULITIS ( 1 patients )
STAPHYLOCOCCAL INFECTION ( 1 patients )
MENINGITIS ( 1 patients )
PULMONARY CAVITATION ( 1 patients )
HERPES ZOSTER ( 1 patients )
PLEURISY ( 1 patients )
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 1 patients )
HYPERTROPHY ( 1 patients )
FUNGAL ENDOCARDITIS ( 1 patients )
IMMUNOSUPPRESSION ( 1 patients )
MYCETOMA MYCOTIC ( 1 patients )
CYTOMEGALOVIRUS INFECTION ( 1 patients )
PNEUMONIA CYTOMEGALOVIRAL ( 1 patients )
TRANSPLANT ( 1 patients )
BRAIN ABSCESS ( 1 patients )
FUNGAL TEST POSITIVE ( 1 patients )
NEUTROPENIA ( 1 patients )
DIFFUSE LARGE B-CELL LYMPHOMA ( 1 patients )
INTESTINAL MASS ( 1 patients )
PNEUMONIA NECROTISING ( 1 patients )
TUBERCULOSIS ( 1 patients )
FUNGUS SPUTUM TEST POSITIVE ( 1 patients )
OEDEMA ( 1 patients )
ABDOMINAL ABSCESS ( 1 patients )
EAR INFECTION FUNGAL ( 1 patients )
PREMEDICATION ( 1 patients )
UPPER RESPIRATORY FUNGAL INFECTION ( 1 patients )
SINUSITIS FUNGAL ( 1 patients )
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER ( 1 patients )
VITRITIS ( 1 patients )
GRAFT VERSUS HOST DISEASE ( 1 patients )
SKIN LESION ( 1 patients )
ENDOPHTHALMITIS ( 1 patients )
CENTRAL NERVOUS SYSTEM INFECTION ( 1 patients )
HERPES SIMPLEX ( 1 patients )
PERITONITIS ( 1 patients )
MENINGITIS COCCIDIOIDES ( 1 patients )
MENINGITIS FUNGAL ( 1 patients )
CNS VENTRICULITIS ( 1 patients )
PNEUMONIA ASPERGILLUS ( 1 patients )
MUCOSAL INFLAMMATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with FORMICATION:

NIASPAN (164 patients)
ASPIRIN (164 patients)
SEROQUEL (162 patients)
LYRICA (145 patients)
CHANTIX (109 patients)
ZOLOFT (105 patients)
CYMBALTA (102 patients)
DURAGESIC-100 (93 patients)
XANAX (86 patients)
CLONAZEPAM (82 patients)
LIPITOR (78 patients)
FENTANYL (76 patients)
LISINOPRIL (74 patients)
OXYCONTIN (74 patients)
FOSAMAX (74 patients)
OMEPRAZOLE (72 patients)
SYNTHROID (71 patients)
EFFEXOR XR (70 patients)
PAXIL (65 patients)
NEXIUM (63 patients)
ENBREL (63 patients)
METHOTREXATE (63 patients)
HUMIRA (62 patients)
REMICADE (60 patients)
SIMVASTATIN (59 patients)
KLONOPIN (59 patients)
NEURONTIN (56 patients)
BETASERON (55 patients)
TYSABRI (55 patients)
SINGULAIR (52 patients)
AMBIEN (51 patients)
ALBUTEROL (50 patients)
SIMCOR (49 patients)
DIOVAN (49 patients)
CRESTOR (48 patients)
FENTANYL-100 (48 patients)
FOLIC ACID (47 patients)
HYDROCHLOROTHIAZIDE (47 patients)
RITUXIMAB (47 patients)
LEVAQUIN (47 patients)
PREDNISONE (46 patients)
VICODIN (45 patients)
AMITRIPTYLINE HCL (45 patients)
RIVOTRIL (44 patients)
FRONTAL (43 patients)
ATENOLOL (43 patients)
GEODON (43 patients)
TOPAMAX (43 patients)
METFORMIN HCL (41 patients)
PROZAC (40 patients)
DIAZEPAM (39 patients)
VALIUM (39 patients)
CHAMPIX (38 patients)
AMLODIPINE (37 patients)
LEVOTHYROXINE SODIUM (36 patients)
CELEXA (36 patients)
REQUIP (36 patients)
AVONEX (36 patients)
TRAZODONE HCL (35 patients)
BENADRYL (35 patients)
TRILEPTAL (35 patients)
CONCERTA (35 patients)
PROTONIX (34 patients)
LASIX (34 patients)
TOPROL-XL (34 patients)
FLUOXETINE (34 patients)
ABILIFY (33 patients)
NORVASC (33 patients)
CELEBREX (33 patients)
WELLBUTRIN (33 patients)
STRATTERA (33 patients)
MAGNEVIST (33 patients)
METHADONE HCL (32 patients)
IBUPROFEN (32 patients)
ATIVAN (32 patients)
CLONIDINE (31 patients)
ADVAIR DISKUS 100/50 (31 patients)
VIOXX (31 patients)
GABAPENTIN (31 patients)
LEXAPRO (31 patients)
PAROXETINE HCL (31 patients)
EFFEXOR (31 patients)
COPEGUS (30 patients)
PRILOSEC (30 patients)
FISH OIL (30 patients)
NAPROXEN (29 patients)
PREMARIN (29 patients)
FORTEO (29 patients)
CALCIUM (29 patients)
LORAZEPAM (29 patients)
TRAMADOL HCL (28 patients)
AVELOX (28 patients)
MORPHINE (27 patients)
PEGASYS (27 patients)
SOLU-MEDROL (27 patients)
DURAGESIC (27 patients)
ACETAMINOPHEN (26 patients)
ACTIQ (26 patients)
PERCOCET (26 patients)
PAXIL CR (25 patients)
TIBOLONE (25 patients)
ALL OTHER THERAPEUTIC PRODUCTS (25 patients)
RISPERDAL (25 patients)
METOPROLOL TARTRATE (25 patients)
PREVACID (24 patients)
PLAVIX (23 patients)
DEPAKOTE (23 patients)
SUBOXONE (23 patients)
ZETIA (23 patients)
ZOCOR (23 patients)
OXYCODONE HCL (23 patients)
LAMICTAL (22 patients)
MULTI-VITAMIN (22 patients)
COUMADIN (22 patients)
ULTRAM (21 patients)
RANITIDINE (21 patients)
ALPRAZOLAM (21 patients)
RIBAVIRIN (21 patients)
FLEXERIL (21 patients)
ZYPREXA (21 patients)
ENALAPRIL MALEATE (21 patients)
MORPHINE SULFATE (21 patients)
CITALOPRAM (20 patients)
LANSOPRAZOLE (20 patients)
BACLOFEN (20 patients)
ULTRACET (20 patients)
ZYRTEC (19 patients)
LORATADINE (19 patients)
VITAMIN D (19 patients)
PRISTIQ (19 patients)
DICLOFENAC SODIUM (19 patients)
SEROQUEL XR (19 patients)
LITHIUM CARBONATE (19 patients)
NASONEX (19 patients)
SOMA (18 patients)
METFORMIN (18 patients)
CITALOPRAM HYDROBROMIDE (18 patients)
DIGOXIN (18 patients)
LANTUS (18 patients)
PROVIGIL (18 patients)
PROFENID (17 patients)
VITAMIN B COMPLEX CAP (17 patients)
MS CONTIN (17 patients)
ALLOPURINOL (17 patients)
BEXTRA (17 patients)
FORASEQ (17 patients)
PRESSOTEC (16 patients)
ACTONEL (16 patients)
ACTOS (16 patients)
PREDNISONE TAB (16 patients)
VITAMINS (16 patients)
VOLTAREN (16 patients)
BYETTA (16 patients)
TEGRETOL (16 patients)
PHENERGAN (16 patients)
MIRAPEX (16 patients)
DORFLEX (16 patients)
FRONTAL XR (16 patients)
ATORVASTATIN CALCIUM (16 patients)
MABTHERA (16 patients)
PAROXETINE (16 patients)
BETAFERON (15 patients)
SANDOSTATIN LAR (15 patients)
REBIF (15 patients)
LEVOXYL (15 patients)
METOPROLOL (15 patients)
LORTAB (15 patients)
LOSARTAN POTASSIUM (15 patients)
WELLBUTRIN XL (15 patients)
ASCORBIC ACID (15 patients)
GABITRIL (15 patients)
AVANDIA (15 patients)
MIRENA (14 patients)
LINDANE (14 patients)
REMERON (14 patients)
VYTORIN (14 patients)
ZANAFLEX (14 patients)
SPIRIVA (14 patients)
HYDROCODONE (14 patients)
FENTANYL CITRATE (14 patients)
KETOPROFEN (14 patients)
PROVERA (14 patients)
VALTREX (14 patients)
VISTARIL (14 patients)
LOVASTATIN (13 patients)
KEPPRA (13 patients)
WELLBUTRIN SR (13 patients)
PROMETHAZINE (13 patients)
PROPRANOLOL (13 patients)
UNKNOWN GBCA (13 patients)
REGLAN (13 patients)
XYREM (13 patients)
DURAGESIC-50 (13 patients)
VITAMIN B-12 (13 patients)
LIORESAL (13 patients)
CALCIUM CARBONATE (13 patients)
INDERAL (13 patients)
DILAUDID (13 patients)
OLCADIL (13 patients)
BONIVA (13 patients)
RENAGEL (13 patients)
GLYBURIDE (13 patients)
CAPTOPRIL (12 patients)
DEPAKENE (12 patients)
PARACETAMOL (12 patients)
ETHINYL ESTRADIOL TAB (12 patients)
LENDORMIN (12 patients)
TEMAZEPAM (12 patients)
LEVONORGESTREL (12 patients)
LEVONORGESTREL AND ETHINYL ESTRADIOL (12 patients)
Most common side effects for patients taking VORICONAZOLE:
PYREXIA (342 patients)
PNEUMONIA (302 patients)
DRUG INTERACTION (289 patients)
RESPIRATORY FAILURE (261 patients)
DRUG INEFFECTIVE (260 patients)
DEATH (240 patients)
FEBRILE NEUTROPENIA (223 patients)
RENAL FAILURE ACUTE (214 patients)
SEPTIC SHOCK (209 patients)
SEPSIS (207 patients)
DIARRHOEA (201 patients)
MULTI-ORGAN FAILURE (182 patients)
HYPOTENSION (176 patients)
ASPERGILLOSIS (167 patients)
BRONCHOPULMONARY ASPERGILLOSIS (162 patients)
PANCYTOPENIA (157 patients)
DYSPNOEA (146 patients)
RENAL FAILURE (138 patients)
NEUTROPENIA (136 patients)
FUNGAL INFECTION (125 patients)
NEPHROPATHY TOXIC (125 patients)
GRAFT VERSUS HOST DISEASE (121 patients)
NAUSEA (114 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (109 patients)
VOMITING (105 patients)
THROMBOCYTOPENIA (105 patients)
PLEURAL EFFUSION (104 patients)
HEPATOTOXICITY (97 patients)
PLATELET COUNT DECREASED (97 patients)
BLOOD BILIRUBIN INCREASED (95 patients)
CONFUSIONAL STATE (91 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (89 patients)
WHITE BLOOD CELL COUNT DECREASED (88 patients)
HEADACHE (85 patients)
INFECTION (85 patients)
HYPOKALAEMIA (84 patients)
HAEMOGLOBIN DECREASED (83 patients)
ACUTE MYELOID LEUKAEMIA (82 patients)
PAIN (80 patients)
DRUG LEVEL INCREASED (80 patients)
ALANINE AMINOTRANSFERASE INCREASED (78 patients)
LIVER FUNCTION TEST ABNORMAL (78 patients)
CONVULSION (75 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (75 patients)
ANAEMIA (74 patients)
CONDITION AGGRAVATED (74 patients)
DISEASE PROGRESSION (73 patients)
NEUROPATHY PERIPHERAL (73 patients)
PHOTOSENSITIVITY REACTION (73 patients)
PULMONARY OEDEMA (72 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (71 patients)
HEPATIC FUNCTION ABNORMAL (69 patients)
CYTOMEGALOVIRUS INFECTION (69 patients)
ABDOMINAL PAIN (68 patients)
COUGH (68 patients)
BACTERIAL INFECTION (68 patients)
FATIGUE (67 patients)
TACHYCARDIA (65 patients)
DRUG RESISTANCE (64 patients)
BLOOD CREATININE INCREASED (64 patients)
BRADYCARDIA (64 patients)
VENOOCCLUSIVE LIVER DISEASE (64 patients)
MUSCULAR WEAKNESS (63 patients)
CELLULITIS (62 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (62 patients)
CHOLESTASIS (62 patients)
LUNG INFILTRATION (61 patients)
HYPOXIA (60 patients)
OEDEMA PERIPHERAL (60 patients)
LUNG INFECTION (60 patients)
SQUAMOUS CELL CARCINOMA (59 patients)
CARDIAC ARREST (58 patients)
HYPERTENSION (58 patients)
DILATATION INTRAHEPATIC DUCT ACQUIRED (58 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (56 patients)
DEHYDRATION (55 patients)
RESPIRATORY DISTRESS (54 patients)
RENAL IMPAIRMENT (54 patients)
HALLUCINATION (53 patients)
CEREBRAL HAEMORRHAGE (53 patients)
RASH (52 patients)
ACUTE GRAFT VERSUS HOST DISEASE (51 patients)
METABOLIC ACIDOSIS (51 patients)
ATRIAL FIBRILLATION (50 patients)
PNEUMONIA FUNGAL (49 patients)
ASTHENIA (49 patients)
LUNG DISORDER (49 patients)
PERICARDIAL EFFUSION (48 patients)
DIZZINESS (47 patients)
HYPERBILIRUBINAEMIA (47 patients)
ELECTROCARDIOGRAM QT PROLONGED (46 patients)
HEPATIC ENZYME INCREASED (46 patients)
LIVER DISORDER (45 patients)
PAIN IN EXTREMITY (45 patients)
CARDIAC FAILURE (45 patients)
ASCITES (45 patients)
MUCOSAL INFLAMMATION (44 patients)
STAPHYLOCOCCAL INFECTION (44 patients)
INTERSTITIAL LUNG DISEASE (44 patients)
HYPOAESTHESIA (44 patients)
CYSTITIS HAEMORRHAGIC (43 patients)
ENCEPHALOPATHY (42 patients)
PNEUMONITIS (42 patients)
CARDIO-RESPIRATORY ARREST (42 patients)
ENTEROCOCCAL INFECTION (42 patients)
EPISTAXIS (41 patients)
NEUTROPHIL COUNT DECREASED (40 patients)
DRUG TOXICITY (40 patients)
ERYTHEMA (40 patients)
ACIDOSIS (38 patients)
PNEUMOTHORAX (38 patients)
BACK PAIN (38 patients)
HEPATIC FAILURE (38 patients)
PANCREATITIS (37 patients)
CONSTIPATION (37 patients)
MENTAL STATUS CHANGES (36 patients)
HYPERKALAEMIA (36 patients)
CANDIDIASIS (36 patients)
SOMNOLENCE (36 patients)
SYSTEMIC MYCOSIS (35 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (35 patients)
HEPATIC CIRRHOSIS (35 patients)
TORSADE DE POINTES (35 patients)
PSEUDOMONAS INFECTION (35 patients)
NEUROTOXICITY (34 patients)
ATELECTASIS (34 patients)
OEDEMA (34 patients)
HYPOMAGNESAEMIA (34 patients)
HAEMOPTYSIS (34 patients)
ACUTE MYELOID LEUKAEMIA RECURRENT (33 patients)
BLOOD CULTURE POSITIVE (33 patients)
GASTROINTESTINAL HAEMORRHAGE (33 patients)
LEUKOENCEPHALOPATHY (33 patients)
RHABDOMYOLYSIS (33 patients)
SCEDOSPORIUM INFECTION (33 patients)
TRANSAMINASES INCREASED (32 patients)
VISUAL IMPAIRMENT (32 patients)
CHRONIC GRAFT VERSUS HOST DISEASE (32 patients)
MALAISE (32 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (32 patients)
DEPRESSION (32 patients)
LYMPHADENOPATHY (32 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (32 patients)
PARAESTHESIA (32 patients)
SINUSITIS (32 patients)
HYPONATRAEMIA (32 patients)
CHILLS (31 patients)
HAEMATOCRIT DECREASED (31 patients)
NERVOUS SYSTEM DISORDER (31 patients)
CARDIAC FAILURE CONGESTIVE (31 patients)
HYPERGLYCAEMIA (31 patients)
ZYGOMYCOSIS (30 patients)
VISION BLURRED (30 patients)
ARRHYTHMIA (30 patients)
LEUKOPENIA (29 patients)
ESCHERICHIA INFECTION (29 patients)
PULMONARY HAEMORRHAGE (29 patients)
HAEMATURIA (29 patients)
JAUNDICE (29 patients)
CYTOMEGALOVIRUS TEST POSITIVE (29 patients)
LUNG NEOPLASM (28 patients)
WEIGHT INCREASED (28 patients)
DRUG LEVEL DECREASED (28 patients)
ANXIETY (28 patients)
FALL (28 patients)
STEM CELL TRANSPLANT (28 patients)
LEUKOCYTOSIS (27 patients)
TACHYPNOEA (27 patients)
RENAL FAILURE CHRONIC (27 patients)
HYPOPHOSPHATAEMIA (27 patients)
TUMOUR LYSIS SYNDROME (27 patients)
LETHARGY (27 patients)
LYMPHOPENIA (27 patients)
CAPILLARY LEAK SYNDROME (27 patients)
AGITATION (26 patients)
OXYGEN SATURATION DECREASED (26 patients)
CYTOMEGALOVIRUS VIRAEMIA (26 patients)
STOMATITIS (26 patients)
HEPATIC ENCEPHALOPATHY (26 patients)
FEELING ABNORMAL (26 patients)
VENOOCCLUSIVE DISEASE (26 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (26 patients)
BLOOD UREA INCREASED (26 patients)
WEIGHT DECREASED (26 patients)
HAEMORRHAGE (25 patients)
COMA (25 patients)
DYSPHAGIA (25 patients)
CLOSTRIDIUM DIFFICILE COLITIS (25 patients)
ACUTE RESPIRATORY FAILURE (25 patients)
POLYNEUROPATHY (25 patients)
BLOOD PRESSURE DECREASED (25 patients)
BLOOD GLUCOSE INCREASED (25 patients)
ACTINIC KERATOSIS (24 patients)
MALIGNANT NEOPLASM PROGRESSION (24 patients)
TRANSPLANT REJECTION (24 patients)
RENAL TUBULAR NECROSIS (24 patients)
LYMPHOPROLIFERATIVE DISORDER (24 patients)
HERPES ZOSTER (24 patients)
HYPOGLYCAEMIA (24 patients)
SYNCOPE (24 patients)
SKIN LESION (24 patients)
MYALGIA (24 patients)
HEPATORENAL SYNDROME (24 patients)
HEPATIC LESION (24 patients)
DECREASED APPETITE (24 patients)
BONE MARROW FAILURE (23 patients)